biotechwiz.com Report : Visit Site

Technical data of the biotechwiz.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host biotechwiz.com. Currently, hosted in United Kingdom and its service provider is Simply Transit Ltd .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

 biotechwiz - news,views & insights on biotechnology skip to posts current news bytes cutting edge general inspiring interviews intellectual property rights in the field of biotechnology microbiome project plant biotechnology puzzle over this! stem cell research uncategorized wheat genome sequence biotechwiz news,views & insights on biotechnology home the learning academy contact us about us a glossary of terms belgian scientists develop way to detect superparasites institute of tropical medicine antwerp july 26, 2012 at 5:33pm07 dr shyamala pillai shah no comments belgian scientists of the institute of tropical medicine (itm) in antwerp, belgium made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. after sequencing the complete genome of leishmania donovani (a parasite causing one of the most important tropical diseases after malaria) in hundreds of clinical isolates, they identified a series of mutations specific of ‘superparasites’ and developed a simple assay that should allow tracking them anywhere. this eu-funded research was done in collaboration with the wellcome trust sanger institute in uk and clinical partners of the banaras hindu university (india) and the bp koirala institute of health sciences (nepal); it is published in the last issue of the journal of infectious diseases. leishmania is a unicellular parasite that is transmitted through the bite of sandflies and occurs mainly in latin-america, east-africa, asia and countries around the mediterranean sea. the parasite causes a disease called leishmaniasis which can range from self-healing cutaneous to deadly visceral disease, depending on the infecting species. recently, the world health organisation estimated up to 1,6 million of new cases of leishmaniasis every year, affecting essentially the poorest of the poor. in comparison to these figures, the hundreds of imported cases reported among travelers appear a drop of water in the ocean. some of these parasites are more dangerous than others, among them those causing visceral leishmaniasis, a clinical form which is lethal in the absence of treatment. recently, the same group of scientists reported among these (already) dangerous microbes, the existence of ‘superparasites’ in the indian sub-continent, which are drug resistant and at the same time also better equipped to cope with our immune system. to our knowledge, it is the first time such a doubly armed organism is found in nature. these superparasites could jeopardize current efforts to control this devastating disease. the european commission currently supports a series of research projects to develop new drugs against this type of parasites or to protect the few existing ones against the development of resistance (see http://www.leishrisk.net/leishrisk/). in the context of the kaladrug project, the belgian scientists of itm, together with british colleagues of the wellcome trust sanger institute and indian and nepalese clinical colleagues, unraveled the dna code of leishmania using state-of-the-art genomic technologies while aiming to discover features allowing to track superparasites. the scientists found a series of mutations that were specific for these drug resistant and more virulent microbes and developed an easy-to-apply assay that would allow to detect them rapidly. “thanks to the discovery of these mutations, made possible through funding by the european commission, the spread and emergence of these drug resistant parasites can be more efficiently monitored, contributing to a better and more adequate control of the parasite and the disease it causes.” says dr manu vanaerschot (itm), first author of the paper. “we hope that this finding will ultimately pave the way to a field applicable drug resistance detection device not only for pentavalent antimonials but for all antileishmanial drugs. this is an important breakthrough which will help immensely in the control of the menace of leishmaniasis”, says shyam sundar, from the banaras hindu university, a world authority in clinical research. technological revolutions during the last years have allowed a huge effort of sequencing the genome of hundreds of microbes. this type of research provides an unprecedented potential for new solutions to fight these pathogens by revealing their achilles heal, so to say. these technologies can reveal the microbes true identity, offering new targets for drugs or vaccines and allowing scientists to track them. “through the application of the latest technologies on precious clinical material to identify easy-to-use markers we strengthen our position among the world top in the field of translational research for infectious diseases and at the same time benefit those, often poor, patients that are usually most neglected in the society”, says prof dujardin (itm), coordinator of the kaladrug project. “this project also clearly highlights the inestimable value of involving local clinical partners in the affected regions. here, the european commission plays an important role by funding fundamental research that at the same time provides solutions for clinical or epidemiological challenges.” this article is reprinted from alphagalileo.org current news bytes banaras hind university , bp koirala institute of health sciences nepal , drug resistant pathogens , institute of tropical medicine (itm) antwerp , journal of infectious diseases. , leishmania donovani , leishmaniasis , microbial pathogens , molecular biology research , shyam sundar , superparasites , wellcome trust sanger institute , whole genome sequencing read more zooming in on bacterial weapons in 3d max-planck-gesellschaft july 26, 2012 at 5:33pm07 dr shyamala pillai shah no comments the plague, bacterial dysentery, and cholera have one thing in common: these dangerous diseases are caused by bacteria which infect their host using a sophisticated injection apparatus. through needle-like structures, they release molecular agents into their host cell, thereby evading the immune response. researchers at the max planck institute for biophysical chemistry in göttingen in cooperation with colleagues at the max planck institute for infection biology in berlin and the university of washington in seattle (usa) have now elucidated the structure of such a needle at atomic resolution. their findings might contribute to drug tailoring and the development of strategies which specifically prevent the infection process. hundreds of tiny hollow needles sticking out of the bacterial membrane – it is a treacherous tool that makes pathogens causing plague or cholera so dangerous. together with a base, embedded in the membrane, these miniature syringes constitute the so-called type iii secretion system – an injection apparatus through which the pathogens introduce molecular agents into their host cell. there, these substances manipulate essential metabolic processes and disable the immune defines of the infected cells. the consequences are fatal as the pathogens can now spread within the organism without hindrance. to date, traditional antibiotics are prescribed to fight the infection. however, as some bacterial strains succeed in developing resistances, researchers worldwide seek to discover more specific drugs. the exact structure of the 60 to 80 nanometre (60 to 80 millionths of a millimetre) long and about eight nanometre wide needles has so far been unknown. classical methods such as x-ray crystallography or electron microscopy failed or yielded wrong model structures. not crystallisable and insoluble, the needle resisted all attempts to decode its atomic structure. therefore adam lange and stefan becker at the max planck institute for biophysical chemistry together with a team of physicists, biologists and chemists chose a completely novel approach. in cooperation with david baker at the university of washington, and michael kolbe at the max planck institute for infect

URL analysis for biotechwiz.com

http://biotechwiz.com/?tag=miami-children%e2%80%99s-hospital-research-institute
http://biotechwiz.com/?m=200909
http://biotechwiz.com/?tag=nanotechnology
http://biotechwiz.com/?paged=4
http://biotechwiz.com/?cat=387
http://biotechwiz.com/?p=616#comments
http://biotechwiz.com/?tag=university-of-bristol
http://biotechwiz.com/?m=200912
http://biotechwiz.com/?tag=solid-state-nmr-spectroscopy
http://biotechwiz.com/?tag=cellular-reprogramming
http://biotechwiz.com/?tag=agronomic-cultivars
http://biotechwiz.com/?tag=pathogenicity
http://biotechwiz.com/?tag=macro-assisted-selection
http://biotechwiz.com/?tag=mike-bevan
http://biotechwiz.com/?tag=first-human-stem-cell-trials
bris.ac.uk
jic.ac.uk
cerealsdb.uk.net

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: BIOTECHWIZ.COM
Registry Domain ID: 1568060003_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.PublicDomainRegistry.com
Registrar URL: http://www.publicdomainregistry.com
Updated Date: 2017-08-31T02:36:40Z
Creation Date: 2009-09-05T13:09:30Z
Registry Expiry Date: 2018-09-05T13:09:30Z
Registrar: PDR Ltd. d/b/a PublicDomainRegistry.com
Registrar IANA ID: 303
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2013775952
Domain Status: ok https://icann.org/epp#ok
Name Server: NS3.HOST4CHEAP.ORG
Name Server: NS4.HOST4CHEAP.ORG
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-09-29T08:21:26Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR PDR Ltd. d/b/a PublicDomainRegistry.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =biotechwiz.com

  PORT 43

  TYPE domain

DOMAIN

  NAME biotechwiz.com

  CHANGED 2017-08-31

  CREATED 2009-09-05

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS3.HOST4CHEAP.ORG 85.234.150.193

  NS4.HOST4CHEAP.ORG 85.234.150.193

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .